BioRestorative Therapies Secures European Patent Allowance for ThermoStem® Metabolic Disease Platform Expanding Intellectual Property Protection Through 2040
BioRestorative receives European patent allowance for ThermoStem® platform, enhancing metabolic treatment potential until 2040.Quiver AI SummaryBioRestorative Therapies, Inc. announced that the European...
BioRestorative Therapies to Present in The Jan 26th Virtual Investor Summit Microcap Event
Melville, New York--(Newsfile Corp. - January 17, 2023) - BioRestorative Therapies (NASDAQ: BRTX) ("BioRestorative", "BRTX" or the "Company"), a clinical stage company focused on stem cell-based therapies,...